- In May 2022, Anja Health secured USD4.5 million in seed funding to enhance access to cord blood stem cell banking for all individuals, regardless of race, socioeconomic status, or income. This funding will bolster the company's leadership team, drive strategic growth, and strengthen community engagement
- In April 2022, Pluristyx, a biotechnology company specializing in advanced therapeutic tools and services, partnered with Accelerated Biosciences, a leader in regenerative medicine known for its proprietary human trophoblast stem cells (hTSCs), to create clinical-grade hESC banks following GMP guidelines
